The Central Government has introduced stricter regulations for certain alcohol-containing medicines by amending the Drugs Rules, 1945. Under the new notification, all oral formulations containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml will now come under Schedule H1.
The move means these medicines will no longer be freely available over the counter and can only be dispensed with a valid prescription from a registered medical practitioner.
The amendment aims to address concerns over the misuse of certain cough syrups, tonics and other oral medicinal products containing higher levels of alcohol. By placing them under Schedule H1, the government intends to improve monitoring, promote responsible dispensing and reduce the possibility of abuse.
What Changes for Pharmacies?
Under Schedule H1 regulations, pharmacies selling these medicines will have to follow stricter compliance measures. They must:
- Dispense the medicines only against a valid prescription.
- Maintain a separate record of sales.
- Preserve prescriptions and dispensing details for at least three years for inspection by drug regulators.
The new rules are similar to existing controls applied to certain antibiotics, anti-tuberculosis medicines and other drugs requiring enhanced monitoring.
Why Has the Government Introduced This Change?
Many pharmaceutical formulations use ethyl alcohol as a solvent or preservative. While these medicines are considered safe when used correctly, regulators have raised concerns about products with higher alcohol content being misused due to easy availability.
Recommendations from regulatory bodies, including the Drugs Consultative Committee and the Drugs Technical Advisory Board, supported bringing such medicines under tighter control.
What Is Schedule H1?
Schedule H1 is a category of medicines introduced in 2013 under the Drugs and Cosmetics Rules to improve oversight of drugs with a higher risk of misuse or inappropriate use.
Medicines listed under Schedule H1 require:
- Mandatory prescription before purchase.
- Specific warnings on labels.
- Detailed record maintenance by pharmacies.
- Availability of sale records for regulatory inspection.
The category initially included certain advanced antibiotics, anti-tuberculosis medicines and habit-forming drugs, and has gradually expanded to include other medicines requiring additional monitoring.
What Does This Mean for Patients?
The change does not mean these medicines are unsafe or banned. Patients who need these formulations will continue to receive them through a doctor’s prescription.
Patients should:
- Use the medicine only as prescribed.
- Avoid sharing medicines with others.
- Consult healthcare providers before combining alcohol-containing medicines with alcoholic beverages.
Unsupervised consumption of such medicines may increase the risk of side effects, including drowsiness and impaired coordination, especially among children, elderly people and individuals with certain health conditions.
A Step Towards Safer Medicine Use
The inclusion of high-alcohol oral medicines under Schedule H1 reflects the government’s broader effort to improve drug safety and strengthen regulation in India.
The move focuses on ensuring that medicines containing higher concentrations of ethyl alcohol are used responsibly while maintaining access for patients who genuinely require them.
By improving traceability and encouraging proper prescription practices, the new regulation aims to create a safer and more controlled medicine distribution system.
